KPHMW — KIORA PHARMACEUTICALS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1372514 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | 0 | -2,330,354 | -2,192,980 | 24,253,300 | 8,696,570 | 8,126,764 |
| Dec 2024 | 0 | 0 | -3,602,237 | -3,413,326 | 36,484,484 | 3,792,322 | 10,724,708 |
| Dec 2023 | 0 | 0 | -5,918,568 | -5,762,941 | 13,711,870 | 2,454,684 | 7,602,216 |
| Dec 2022 | 0 | 0 | -3,703,035 | -5,119,339 | 18,678,259 | 5,964,556 | 7,270,659 |
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 16,020,000 | 4,510,288 | 3,594,733 | 36,484,484 | 10,724,708 | 25,759,776 | — |
| Dec 2023 | 0 | -12,586,896 | -12,513,896 | 13,711,870 | 7,602,216 | 6,109,654 | — |
| Dec 2022 | 56,891 | -12,309,523 | -13,583,610 | 18,678,259 | 7,270,659 | 11,407,600 | — |
| Dec 2021 | 1,141 | -14,235,768 | -13,770,685 | 20,130,308 | 5,551,260 | 14,579,048 | — |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-11,212,612
OpCashFlow TTM
$0
Assets (Latest)
$24,253,300
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.06T | $1183.46 | — |
| JNJ | JOHNSON & JOHNSON | $653.61B | $271.22 | — |
| ABBV | AbbVie Inc. | $467.12B | $264.34 | — |
| MRK | Merck & Co., Inc. | $367.07B | $148.78 | — |
| NVS | NOVARTIS AG | $276.48B | $145.46 | — |
Recent Insider Activity
No insider activity indexed for this ticker.